Research and Markets
C5a-R Antagonists 2010 Analysis - A Compilation of Current Active Projects in Research & Development of C5a & C5aR Antagonists
Published in Vaccine Weekly, November 17th, 2010
The present Competitive Intelligence Report about Complement C5a & C5a Receptor Antagonists provides a competitor evaluation in the field of R&D projects of antagonists used to interfere with the interaction of complement C5a and its receptor for the treatment of inflammatory diseases as of October 2010. The molecules used to antagonize the interaction of C5a with C5aR include antibodies, proteins, peptides, nucleic acid macromolecules such as aptamers, vaccines and small...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2010-11-17)
More Articles from Vaccine Weekly
- Medical Schools
Hidden costs of applying to medical school will deter poorer students - Peptides and Proteins
Pfenex Inc. Launches reagentproteins.com - Chagas Disease
Scientists at University of Texas at El Paso, Department of Biological Sciences describe research in Chagas disease - Interleukin-16 Receptors
Studies from University of Cape Town, Institute of Infectious Diseases and Molecular Medicine update current data on interleukin-16 receptors - Francisella
Study results from M.C. Parra and colleagues update understanding of francisella - Cancer
Advaxis to Present at the Fifth Annual Singular Research "Best of the Uncovereds" Conference - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
